Loading...

ANZGOG contributes to global GCIG Code of Conduct on diversity in gynaecological cancer clinical trials

ANZGOG contributes to global GCIG Code of Conduct on diversity in gynaecological cancer clinical trials ANZGOG has contributed to a new international publication in the International Journal of Gynecological Cancer introducing the GCIG Code of Conduct [...]

ANZGOG contributes to global GCIG Code of Conduct on diversity in gynaecological cancer clinical trials2026-07-08T11:15:06+10:00

Australia’s fastest-growing women’s cancer is largely preventable — yet most women have never heard of it

Australia’s fastest-growing women’s cancer is largely preventable — yet most women have never heard of it MEDIA RELEASE 1 June 2026 National data confirms uterine cancer incidence has more than doubled in 25 years, with diagnoses among younger [...]

Australia’s fastest-growing women’s cancer is largely preventable — yet most women have never heard of it2026-06-05T09:43:10+10:00

Federal Budget commitment to medical research funding welcome, but urgent need for gynaecological cancer investment remains

Federal Budget commitment to medical research funding welcome, but urgent need for gynaecological cancer investment remains MEDIA RELEASE 13 May 2026 Federal Budget commitment to medical research funding welcome, but urgent need for gynaecological cancer investment remains  The Australia New Zealand Gynaecological Oncology Group [...]

Federal Budget commitment to medical research funding welcome, but urgent need for gynaecological cancer investment remains2026-05-19T18:34:40+10:00

Championing the people driving progress in gynaecological cancer research

ANZGOG members were recognised for their outstanding contributions to improving outcomes for everyone with a lived experience of gynaecological cancer during the ANZGOG 2026 Annual Scientific Meeting conference dinner. The ANZGOG Recognition Awards are a chance to recognise [...]

Championing the people driving progress in gynaecological cancer research2026-04-22T17:36:19+10:00

STRIVE clinical trial now available in Aotearoa New Zealand to improve outcomes in vulvar cancer

STRIVE clinical trial now available in Aotearoa New Zealand to improve outcomes in vulvar cancer Media Release - 24 February 2026 The Australian New Zealand Gynaecological Oncology Group (ANZGOG) in partnership with the Canadian Cancer Trials Group (CCTG) [...]

STRIVE clinical trial now available in Aotearoa New Zealand to improve outcomes in vulvar cancer2026-04-07T12:58:29+10:00
Go to Top